136 related articles for article (PubMed ID: 2189258)
1. Intracellular processing and immunogenicity of the envelope proteins of human T-cell leukemia virus type I that are expressed from recombinant vaccinia viruses.
Seki M; Sashiyama H; Hayami M; Shida H
Virus Genes; 1990 Feb; 3(3):235-49. PubMed ID: 2189258
[TBL] [Abstract][Full Text] [Related]
2. Effects and virulences of recombinant vaccinia viruses derived from attenuated strains that express the human T-cell leukemia virus type I envelope gene.
Shida H; Hinuma Y; Hatanaka M; Morita M; Kidokoro M; Suzuki K; Maruyama T; Takahashi-Nishimaki F; Sugimoto M; Kitamura R
J Virol; 1988 Dec; 62(12):4474-80. PubMed ID: 3184271
[TBL] [Abstract][Full Text] [Related]
3. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes.
Gherardi MM; Nájera JL; Pérez-Jiménez E; Guerra S; García-Sastre A; Esteban M
J Virol; 2003 Jun; 77(12):7048-57. PubMed ID: 12768024
[TBL] [Abstract][Full Text] [Related]
4. Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I.
Hakoda E; Machida H; Tanaka Y; Morishita N; Sawada T; Shida H; Hoshino H; Miyoshi I
Int J Cancer; 1995 Feb; 60(4):567-70. PubMed ID: 7829272
[TBL] [Abstract][Full Text] [Related]
5. Expression and immunogenicity in rats of recombinant adenovirus 5 DNA plasmids and vaccinia virus containing the HTLV-I env gene.
Kazanji M; Bomford R; Bessereau JL; Schulz T; de Thé G
Int J Cancer; 1997 Apr; 71(2):300-7. PubMed ID: 9139857
[TBL] [Abstract][Full Text] [Related]
6. Mapping of the human immunodeficiency virus type 2 envelope glycoprotein CD4 binding region and fusion domain with truncated proteins expressed by recombinant vaccinia viruses.
Otteken A; Voss G; Hunsmann G
Virology; 1993 May; 194(1):37-43. PubMed ID: 8480426
[TBL] [Abstract][Full Text] [Related]
7. Constructions of vaccinia virus A-type inclusion body protein, tandemly repeated mutant 7.5 kDa protein, and hemagglutinin gene promoters support high levels of expression.
Jin NY; Funahashi S; Shida H
Arch Virol; 1994; 138(3-4):315-30. PubMed ID: 7998837
[TBL] [Abstract][Full Text] [Related]
8. A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.
Dong J; Roth MG; Hunter E
J Virol; 1992 Dec; 66(12):7374-82. PubMed ID: 1331528
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of recombinant vaccinia viruses that display the HIV type 1 envelope glycoprotein on the surface of infectious virions.
Katz E; Moss B
AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1497-500. PubMed ID: 9390748
[TBL] [Abstract][Full Text] [Related]
10. Chimeras between the human immunodeficiency virus (HIV-1) Env and vaccinia virus immunogenic proteins p14 and p39 generate in mice broadly reactive antibodies and specific activation of CD8+ T cell responses to Env.
Collado M; Rodríguez D; Rodríguez JR; Vázquez I; Gonzalo RM; Esteban M
Vaccine; 2000 Jul; 18(27):3123-33. PubMed ID: 10856792
[TBL] [Abstract][Full Text] [Related]
11. Use of persistent infections with vaccinia virus recombinants to introduce alterations in foreign proteins: an application to HIV-1 env protein.
Esteban M; Ramón Rodríguez J; Jimenez V; Rodríguez D
Virus Res; 1996 Dec; 46(1-2):45-56. PubMed ID: 9029776
[TBL] [Abstract][Full Text] [Related]
12. Expression of foreign genes in cultured human primary macrophages using recombinant vaccinia virus vectors.
Broder CC; Kennedy PE; Michaels F; Berger EA
Gene; 1994 May; 142(2):167-74. PubMed ID: 8194748
[TBL] [Abstract][Full Text] [Related]
13. Expression of human endogenous retrovirus type K envelope glycoprotein in insect and mammalian cells.
Tönjes RR; Limbach C; Löwer R; Kurth R
J Virol; 1997 Apr; 71(4):2747-56. PubMed ID: 9060628
[TBL] [Abstract][Full Text] [Related]
14. Recombinant vaccinia virus expression of the bovine leukaemia virus envelope gene and protection of immunized sheep against infection.
Portetelle D; Limbach K; Burny A; Mammerickx M; Desmettre P; Riviere M; Zavada J; Paoletti E
Vaccine; 1991 Mar; 9(3):194-200. PubMed ID: 1645899
[TBL] [Abstract][Full Text] [Related]
15. Screening of HIV-1 Env glycoproteins for the ability to raise neutralizing antibody using DNA immunization and recombinant vaccinia virus boosting.
Richmond JF; Mustafa F; Lu S; Santoro JC; Weng J; O'Connell M; Fenyö EM; Hurwitz JL; Montefiori DC; Robinson HL
Virology; 1997 Apr; 230(2):265-74. PubMed ID: 9143282
[TBL] [Abstract][Full Text] [Related]
16. Effect of the recombinant vaccinia viruses that express HTLV-I envelope gene on HTLV-I infection.
Shida H; Tochikura T; Sato T; Konno T; Hirayoshi K; Seki M; Ito Y; Hatanaka M; Hinuma Y; Sugimoto M
EMBO J; 1987 Nov; 6(11):3379-84. PubMed ID: 2828027
[TBL] [Abstract][Full Text] [Related]
17. Expression of the HTLV-III envelope gene by a recombinant vaccinia virus.
Chakrabarti S; Robert-Guroff M; Wong-Staal F; Gallo RC; Moss B
Nature; 1986 Apr 10-16; 320(6062):535-7. PubMed ID: 3008001
[TBL] [Abstract][Full Text] [Related]
18. Generation and analysis of vaccinia virus recombinants.
Mazzara GP; Destree A; Mahr A
Methods Enzymol; 1993; 217():557-81. PubMed ID: 8474351
[No Abstract] [Full Text] [Related]
19. Immunogenicity of human T cell leukemia virus type-I (HTLV-I) antigens for cytotoxic T lymphocytes in the rat system.
Tanaka Y; Isobe A; Masuda M; Tozawa H; Koyanagi Y; Yamamoto N; Shida H
J Immunol; 1991 Nov; 147(10):3646-52. PubMed ID: 1940363
[TBL] [Abstract][Full Text] [Related]
20. Immune response to E7 protein of human papillomavirus type 16 anchored on the cell surface.
Nemecková S; Stránská R; Subrtová J; Kutinová L; Otáhal P; Hainz P; Maresová L; Sroller V; Hamsíková E; Vonka V
Cancer Immunol Immunother; 2002 Apr; 51(2):111-9. PubMed ID: 11904736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
